We also find Microtubule-actin cross-linking factor 1 (macf1) recently described as a novel radiosensitization target in glioblastomas (45) and Protein NDRG1 (ndrg1) which is over-expressed in glioma resistant to antiangiogenic therapy (46). Here, NDRG1 is linked to central nervous system cancer.